Story Summary: Dr. David Weiner, Chair of Inovioas Scientific Advisory Board, and Niranjan Sardesai, Senior Vice President, SVP, Research and Development will speak on Inovioas DNA vaccine development. aEngineering DNA vaccine potency in vivo results in improved Immunity: Improving Vaccine Immunogenicity and EfficacyaaDevelopment of Universal SynConaC/ DNA Vaccines for Pandemic and Seasonal InfluenzaaAbout Inovio Biomedical CorporationInovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases. Inovio is developing its universal and avian influenza vaccines in collaboration with scientists from the University of Pennsylvania, the National Microbiology Laboratory of the Public Health Agency of Canada, and the NIHas Vaccine Research Center. This press release contains certain forward-looking statements relating to, among other things, our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines….Read the Full Story

Related posts:

1. Inovio Biomedical to Present at Investor Conferences
2. DNA Vaccine Company Inovio Biomedical to Present at Rodman & Renshaw Investor Healthcare Conference
3. Inovio Biomedical to Present at Novel Vaccines: Design & Development
4. Inovio Biomedical to Present at Partnering and Vaccine Conferences
5. Inovio Biomedical to Present at Jesup & amp; Lamont Growth Stock Conference